1032446-30-2 Usage
General Description
(S)-1-(1-benzylpyrrolidin-3-yl)piperazine, also known as BPPI, is a chemical compound that belongs to the class of piperazine derivatives. It is a chiral molecule, meaning it has a non-superimposable mirror image. BPPI has been studied for its potential use in pharmaceuticals, particularly as a ligand for targeting specific receptors in the brain, such as serotonin and dopamine receptors. This makes it a potential candidate for drug development in the treatment of various neurological and psychiatric disorders. Additionally, piperazine derivatives like BPPI have also been investigated for their potential use as organic intermediates in the synthesis of other compounds. However, it is important to note that BPPI and similar compounds should be handled and used with caution due to their potentially hazardous nature.
Check Digit Verification of cas no
The CAS Registry Mumber 1032446-30-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,4,4 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1032446-30:
(9*1)+(8*0)+(7*3)+(6*2)+(5*4)+(4*4)+(3*6)+(2*3)+(1*0)=102
102 % 10 = 2
So 1032446-30-2 is a valid CAS Registry Number.
1032446-30-2Relevant articles and documents
ANTIBACTERIAL QUINOLINE DERIVATIVES
-
Page/Page column 29, (2010/04/23)
The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib): including any stereochemically isomeric form thereof, a pharmaceutically acceptable salt thereof, a N-oxide form thereof or a solvate thereof. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.